Recent Updates
Recently added Catalysts
CLNN Positive Sentiment

Clene to Participate in the Maxim Group Virtual Healthcare Conference

Thursday, June 15, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Clene Inc. will partake in the Maxim Group Virtual Healthcare Conference on June 22, 2023. Rob Etherington, the CEO, will engage in a fireside chat with a senior biotech analyst. This event highlights Clene's focus on neurodegenerative diseases and its commitment to innovation in the biopharmaceutical sector.
Price reaction · baseline $21.2 (2023-06-14 close) · hit after-hours · 2 other CLNN headline(s) in the window, move may be shared
day 0 close · peak
-0.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Clene is actively participating in a significant healthcare conference.
  • The CEO's involvement indicates strong leadership engagement.
  • Focus on neurodegenerative diseases shows commitment to impactful research.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+63%
120-day peak, hindsight
Typical move
5.3%
average across 6 past catalysts
Cash runway
~11 mo
Medium dilution risk
Lead asset
CNMAu8
Phase 2 · Amyotrophic Lateral Sclerosis

Full Press Release Details

SALT LAKE CITY, June 15, 2023 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative diseases, today announced that Rob Etherington, Chief Executive Officer, will participate in a fireside chat with Naz Rahman, Senior Biotech Research Analyst, at the Maxim Group Virtual Healthcare Conference on June 22, 2023 at 1:00 PM ET.
This conference will be live on M-Vest. To attend, click here: Healthcare Virtual Conference | M-Vest.
Contacts:
Media Contact Investor Contact
Ignacio Guerrero-Ros, Ph.D., or David Schull Kevin Gardner
Russo Partners, LLC LifeSci Advisors
Ignacio.guerrero-ros@russopartnersllc.com kgardner@lifesciadvisors.com
David.schull@russopartnersllc.com 617-283-2856
(858) 717-2310

Frequently Asked Questions

When will Clene participate in the virtual healthcare conference?

Clene will participate on June 22, 2023, at 1:00 PM ET.

Who is hosting the fireside chat for Clene?

Rob Etherington will chat with Naz Rahman during the conference.

What is Clene Inc. focused on treating?

Clene Inc. aims to revolutionize treatments for neurodegenerative diseases.

How can attendees access the conference?

The conference will be live on M-Vest for attendees.

ShareAdd on Google
Tags: CLNN Viatris Investor Conferences Healthcare Clene Inc. neurodegenerative diseases healthcare conference Maxim Group Rob Etherington
Last updated: Jun 15, 2023

Biotech snapshot

Cash runway
$10M liquidity · $1M/mo burn
~11 mo
Medium dilution risk
Lead asset
CNMAu8Phase 2
Amyotrophic Lateral Sclerosis →

Catalyst track record

+63%
best trade around CLNN's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for CLNN.

See every catalyst's timing & PoA →